These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22146051)

  • 41. Anti-fungal therapy at the HAART of viral therapy.
    Munro CA; Hube B
    Trends Microbiol; 2002 Apr; 10(4):173-7. PubMed ID: 11912023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonpeptidal P2 ligands for HIV protease inhibitors: structure-based design, synthesis, and biological evaluation.
    Ghosh AK; Kincaid JF; Walters DE; Chen Y; Chaudhuri NC; Thompson WJ; Culberson C; Fitzgerald PM; Lee HY; McKee SP; Munson PM; Duong TT; Darke PL; Zugay JA; Schleif WA; Axel MG; Lin J; Huff JR
    J Med Chem; 1996 Aug; 39(17):3278-90. PubMed ID: 8765511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing the accumulation of active- and nonactive-site mutations in the HIV-1 protease.
    Clemente JC; Moose RE; Hemrajani R; Whitford LR; Govindasamy L; Reutzel R; McKenna R; Agbandje-McKenna M; Goodenow MM; Dunn BM
    Biochemistry; 2004 Sep; 43(38):12141-51. PubMed ID: 15379553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural basis for specificity of retroviral proteases.
    Wu J; Adomat JM; Ridky TW; Louis JM; Leis J; Harrison RW; Weber IT
    Biochemistry; 1998 Mar; 37(13):4518-26. PubMed ID: 9521772
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oximinoarylsulfonamides as potent HIV protease inhibitors.
    Yeung CM; Klein LL; Flentge CA; Randolph JT; Zhao C; Sun M; Dekhtyar T; Stoll VS; Kempf DJ
    Bioorg Med Chem Lett; 2005 May; 15(9):2275-8. PubMed ID: 15837308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors.
    Cassone A; De Bernardis F; Torosantucci A; Tacconelli E; Tumbarello M; Cauda R
    J Infect Dis; 1999 Aug; 180(2):448-53. PubMed ID: 10395861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. X-ray structure of HIV-1 protease tethered dimer complexed to ritonavir.
    Das A; Rao DR; Hosur MV
    Protein Pept Lett; 2007; 14(6):565-8. PubMed ID: 17627597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors.
    Savarino A; Cauda R; Cassone A
    J Infect Dis; 2005 Apr; 191(8):1381-2; author reply 1382-3. PubMed ID: 15776390
    [No Abstract]   [Full Text] [Related]  

  • 49. X-ray structures of Sap1 and Sap5: structural comparison of the secreted aspartic proteinases from Candida albicans.
    Borelli C; Ruge E; Lee JH; Schaller M; Vogelsang A; Monod M; Korting HC; Huber R; Maskos K
    Proteins; 2008 Sep; 72(4):1308-19. PubMed ID: 18384081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: application of comparative molecular field analysis.
    Debnath AK
    J Med Chem; 1999 Jan; 42(2):249-59. PubMed ID: 9925730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of Candida albicans secreted aspartic protease by a novel series of peptidomimetics, also active on the HIV-1 protease.
    Skrbec D; Romeo D
    Biochem Biophys Res Commun; 2002 Oct; 297(5):1350-3. PubMed ID: 12372437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cycloalkylpyranones and cycloalkyldihydropyrones as HIV protease inhibitors: exploring the impact of ring size on structure-activity relationships.
    Romines KR; Morris JK; Howe WJ; Tomich PK; Horng MM; Chong KT; Hinshaw RR; Anderson DJ; Strohbach JW; Turner SR; Mizsak SA
    J Med Chem; 1996 Sep; 39(20):4125-30. PubMed ID: 8831779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bicyclic peptidomimetics targeting secreted aspartic protease 2 (SAP2) from Candida albicans reveal a constrained inhibitory chemotype.
    Calugi C; Trabocchi A; De Bernardis F; Arancia S; Navarra P; Cauda R; Cassone A; Guarna A
    Bioorg Med Chem; 2012 Dec; 20(24):7206-13. PubMed ID: 23123016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure-based design of nonpeptidic HIV protease inhibitors from a cyclooctylpyranone lead structure.
    Romines KR; Watenpaugh KD; Howe WJ; Tomich PK; Lovasz KD; Morris JK; Janakiraman MN; Lynn JC; Horng MM; Chong KT
    J Med Chem; 1995 Oct; 38(22):4463-73. PubMed ID: 7473573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV protease inhibitors.
    Carr A; Cooper DA
    AIDS; 1996; 10 Suppl A():S151-7. PubMed ID: 8883623
    [No Abstract]   [Full Text] [Related]  

  • 56. C2-symmetrical tetrahydroxyazepanes as inhibitors of glycosidases and HIV/FIV proteases.
    Qian X; Morís-Varas F; Fitzgerald MC; Wong CH
    Bioorg Med Chem; 1996 Dec; 4(12):2055-69. PubMed ID: 9022971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural basis of HIV-1 and HIV-2 protease inhibition by a monoclonal antibody.
    Rezacova P; Lescar J; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
    Structure; 2001 Oct; 9(10):887-95. PubMed ID: 11591344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure of secreted aspartic proteinases from Candida. Implications for the design of antifungal agents.
    Abad-Zapatero C; Goldman R; Muchmore SW; Hutchins C; Oie T; Stewart K; Cutfield SM; Cutfield JF; Foundling SI; Ray TL
    Adv Exp Med Biol; 1998; 436():297-313. PubMed ID: 9561233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microtube batch protein crystallization: applications to human immunodeficiency virus type 2 (HIV-2) protease and human renin.
    Pav S; Lubbe K; Dô F; Lamarre D; Pargellis C; Tong L
    Proteins; 1994 Sep; 20(1):98-102. PubMed ID: 7824526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro.
    Gruber A; Speth C; Lukasser-Vogl E; Zangerle R; Borg-von Zepelin M; Dierich MP; Würzner R
    Immunopharmacology; 1999 Apr; 41(3):227-34. PubMed ID: 10428651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.